According to our (Global Info Research) latest study, the global AI-based Sperm Morphology Analysis System market size was valued at US$ 74.08 million in 2025 and is forecast to a readjusted size of US$ 200 million by 2032 with a CAGR of 14.2% during review period.
AI-based Sperm Morphology Analysis Systems are intelligent reproductive diagnostic platforms integrating digital microscopy, automated semen analysis, deep learning image recognition, and machine vision technologies for automated sperm morphology evaluation. These systems are designed to identify, classify, and assess sperm head, midpiece, and tail structures through AI-assisted analysis workflows. Major product forms include fully automated desktop sperm quality analyzers, AI-enhanced CASA systems, live sperm morphology analysis platforms, and AI-assisted sperm selection workstations. Typical systems combine automated optical scanning modules, high-resolution imaging units, temperature-controlled stages, AI morphology analysis software, and database-driven evaluation systems to support sperm concentration testing, motility assessment, morphology classification, abnormality detection, and WHO-standardized semen analysis. Key applications include IVF clinics, reproductive medicine centers, hospital laboratories, and andrology laboratories. In 2025, the global industry average gross margin is estimated at approximately 55% to 65%. Average selling prices are estimated at around USD 20,000 to USD 80,000 per mainstream desktop AI morphology analysis system, while high-end AI-assisted sperm selection platforms integrating robotic manipulation, optical tweezers, or advanced microfluidic technologies are typically priced at approximately USD 80,000 to USD 160,000 per system.
The global AI-based sperm morphology analysis system industry remains in the early transition stage from traditional CASA technologies toward intelligent morphology recognition and automated reproductive diagnostics. The core value of the industry lies in improving the consistency, objectivity, and automation level of sperm morphology evaluation in fertility testing workflows. Upstream supply chains mainly involve optical microscopy components, CMOS imaging sensors, AI algorithm frameworks, and reproductive medicine databases, while midstream activities focus on AI semen analysis platforms and integrated morphology analysis systems. Downstream demand is primarily concentrated in IVF clinics, reproductive medicine centers, hospital laboratories, and andrology testing institutions. Rising male infertility rates, increasing ART penetration, and stronger laboratory standardization requirements are gradually accelerating the adoption of AI-assisted morphology analysis technologies. The current competitive landscape is still dominated by a limited number of companies possessing AI algorithm capabilities, clinical data accumulation, and automated morphology analysis technologies, while traditional CASA vendors are also accelerating product upgrades toward AI-enhanced systems. North America and Europe remain the primary markets for high-end reproductive diagnostic platforms, whereas Asia, particularly China, is entering a rapid commercialization and regulatory approval phase. Industry developments in recent years have included product launches, AI software upgrades, clinical validation expansion, reproductive laboratory digitalization, and selective acquisitions aimed at strengthening intelligent fertility analysis capabilities. The market is gradually evolving from basic semen testing toward AI-assisted diagnosis, live sperm assessment, and intelligent sperm selection applications. Future growth is expected to be driven by increasing AI penetration in fertility laboratories, automation upgrades in high-end IVF centers, and the wider adoption of compact and portable analysis systems. Continuous advancements in deep learning models, machine vision technologies, and cloud-based reproductive databases are expected to improve morphology recognition accuracy, abnormality classification efficiency, and laboratory workflow automation. The industry is also moving toward dynamic real-time sperm analysis, remote diagnostic support, and personalized fertility evaluation solutions. However, challenges including long clinical validation cycles, evolving regulatory standards, limited standardization of AI-assisted morphology interpretation, and relatively slow hospital procurement processes are likely to maintain the industry’s high technical barriers and specialized market structure in the near term.
This report is a detailed and comprehensive analysis for global AI-based Sperm Morphology Analysis System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI-based Sperm Morphology Analysis System market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global AI-based Sperm Morphology Analysis System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global AI-based Sperm Morphology Analysis System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2021-2032
Global AI-based Sperm Morphology Analysis System market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI-based Sperm Morphology Analysis System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI-based Sperm Morphology Analysis System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bonray Biotechnology Co., Ltd., Basecare Medical Device Co., Ltd., Suzhou Boundless Medical Technology Co., Ltd., Medical Electronic Systems, Microptic S.L., PROiSER R+D S.L., Hamilton Thorne Ltd., BAIBYS Fertility Ltd., SAS Medical Technology (Beijing) Co., Ltd., BEION Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
AI-based Sperm Morphology Analysis System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Desktop Integrated Analysis System
Modular CASA-based System
Live Sperm Analysis Platform
AI-assisted Sperm Selection Workstation
Others
Market segment by Analysis Parameter
Comprehensive (Concentration + Motility + Morphology)
Morphology-only
Motility + Concentration Only
Morphology + DNA Fragmentation
Others
Market segment by Application
IVF and ART Centers
Hospital Andrology Laboratories
Clinical Diagnostic Laboratories
Fertility Research Institutions
Veterinary Reproduction
Others
Major players covered
Bonray Biotechnology Co., Ltd.
Basecare Medical Device Co., Ltd.
Suzhou Boundless Medical Technology Co., Ltd.
Medical Electronic Systems
Microptic S.L.
PROiSER R+D S.L.
Hamilton Thorne Ltd.
BAIBYS Fertility Ltd.
SAS Medical Technology (Beijing) Co., Ltd.
BEION Medical
Beijing SpermCapturer Biotechnology Co., Ltd.
Illumicell AI
Minitube GmbH
iSperm
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe AI-based Sperm Morphology Analysis System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of AI-based Sperm Morphology Analysis System, with price, sales quantity, revenue, and global market share of AI-based Sperm Morphology Analysis System from 2021 to 2026.
Chapter 3, the AI-based Sperm Morphology Analysis System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AI-based Sperm Morphology Analysis System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and AI-based Sperm Morphology Analysis System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of AI-based Sperm Morphology Analysis System.
Chapter 14 and 15, to describe AI-based Sperm Morphology Analysis System sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on AI-based Sperm Morphology Analysis System. Industry analysis & Market Report on AI-based Sperm Morphology Analysis System is a syndicated market report, published as Global AI-based Sperm Morphology Analysis System Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AI-based Sperm Morphology Analysis System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.